Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa

被引：0

作者：

Hedner, U ^{[1
]}

机构：

[1] Lund Univ, Malmo Univ Hosp, Dept Coagulat Disorders, S-22100 Lund, Sweden

来源：

THROMBOSIS AND HAEMOSTASIS | 1999年 / 82卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：531 / 539

页数：9

共 50 条

[1] Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
Scharrer, I
HAEMOPHILIA, 1999, 5 (04) : 253 - 259
[2] Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors
Abshire, T.
Kenet, G.
HAEMOPHILIA, 2008, 14 (05) : 898 - 902
[3] Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VIII and IX inhibitors
Barthels, M
THROMBOSIS RESEARCH, 1999, 95 (04) : S31 - S38
[4] Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors
Ingerslev, J
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 425 - 432
[5] Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
Abshire, T
Kenet, G
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) : 899 - 909
[6] Recombinant factor VIIa (NovoSeven(R)) in the treatment of internal bleeding in patients with factor VII and IX inhibitors
Lusher, JM
HAEMOSTASIS, 1996, 26 : 124 - 130
[7] TREATMENT OF PATIENTS WITH FACTOR-VIII AND FACTOR-IX INHIBITORS
NILSSON, IM
BERNTORP, E
FREIBURGHAUS, C
THROMBOSIS AND HAEMOSTASIS, 1993, 70 (01) : 56 - 59
[8] Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
Eichinger, S.
Lubsczyk, B.
Kollars, M.
Traby, L.
Zwiauer, K.
Gleiss, A.
Quehenberger, P.
Kyrle, P. A.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 707 - 713
[9] THE CLINICAL USE OF FACTOR VIIA IN THE TREATMENT OF FACTOR-VIII INHIBITOR PATIENTS
SEREMETIS, SV
SEMINARS IN HEMATOLOGY, 1994, 31 (02) : 53 - 55
[10] RECOMBINANT FACTOR-VIIA FOR TREATMENT OF SERIOUS BLEEDS AND FOR COVER OF SURGICAL-PROCEDURES IN HEMOPHILIACS AND NONHAEMOPHILIACS WITH INHIBITORS TO FACTOR-VIII OR FACTOR-IX
FELDSTEDT, M
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 282 - 282

← 1 2 3 4 5 →